LeMaitre Vascular Inc (LMAT) FinancialsLMATLeMaitre Vascular Inc

Evaluating the bottom line, LeMaitre Vascular, Inc. maintains a gross margin of 72.13%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 28.98%, while the net margin is 24.22%. These profitability ratios, combined with a Return on Equity (ROE) of 16.77%, provide a clear picture of how effectively LMAT converts its operational activities into shareholder value.

In the context of the broader market, LMAT competes directly with industry leaders such as ESTA and XRAY. With a market capitalization of $1.90B, it holds a leading position in the sector. When comparing efficiency, LMAT's gross margin of 72.13% stands against ESTA's 70.64% and XRAY's 54.90%. Such benchmarking helps identify whether LeMaitre Vascular, Inc. is trading at a premium or discount relative to its financial performance.

LeMaitre has shown strong financial performance with Q2 2026 gross margin at 72.13% and a net income increase of 24% year-over-year to $17.1 million, reflecting solid profitability.